Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.77% | 41.13% | -58.25% | -85.99% | 32.68% |
| Total Depreciation and Amortization | 4.59% | 8.11% | 14.18% | -13.98% | 6.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.71% | -71.68% | 122.36% | 439.41% | -72.02% |
| Change in Net Operating Assets | 121.15% | 76.84% | -99.57% | -90.21% | 36.52% |
| Cash from Operations | 35.79% | 31.94% | -39.89% | -48.54% | 21.44% |
| Capital Expenditure | 27.94% | -434.23% | 40.64% | 70.80% | -278.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.41% | 104.45% | -514.37% | -269.56% | 350.83% |
| Cash from Investing | 53.67% | 103.45% | -503.88% | -294.61% | 361.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,216.67% | -99.98% | 555,476.32% | -17.39% | 283.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -129.62% | -926.89% |
| Cash from Financing | 6,216.67% | -99.98% | 271.09% | 4,937.76% | -999.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.21% | -161.38% | -7.17% | 190.84% | 149.24% |